Adenosine kinase and adenosine deaminase inhibition modulate spinal adenosine- and opioid agonist-induced antinociception in mice
- 1 December 1994
- journal article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 271 (1) , 37-46
- https://doi.org/10.1016/0014-2999(94)90262-3
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Morphine Activates ω‐Conotoxin‐Sensitive Ca2+ Channels to Release Adenosine from Spinal Cord SynaptosomesJournal of Neurochemistry, 1993
- Extracellular levels of adenosine and its metabolites in the striatum of awake rats: inhibition of uptake and metabolismActa Physiologica Scandinavica, 1991
- Interdependence of spinal adenosinergic, serotonergic and noradrenergic systems mediating antinociceptionNeuropharmacology, 1987
- Involvement of A2 adenosine receptors in spinal mechanisms of antinociceptionEuropean Journal of Pharmacology, 1987
- Studies on several pyrrolo[2,3-d]pyrimidine analogues of adenosine which lack significant agonist activity at A1 and A2 receptors but have potent pharmacological activity in vivoBiochemical Pharmacology, 1986
- Adenosine-containing neurons in the brain localized by immunocytochemistryJournal of Neuroscience, 1986
- Adenosine metabolism: Modification by S-adenosylhomocysteine and 5′-methylthioadenosineArchives of Biochemistry and Biophysics, 1982
- Potentiation of pharmacological responses to adenosine, in vitro and in vivoGeneral Pharmacology: The Vascular System, 1982
- Activities and some properties of 5′-nucleotidase, adenosine kinase and adenosine deaminase in tissues from vertebrates and invertebrates in relation to the control of the concentration and the physiological role of adenosineBiochemical Journal, 1978
- Tight-binding inhibitors—IV. Inhibition of adenosine deaminases by various inhibitorsBiochemical Pharmacology, 1977